Literature DB >> 8786052

Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China.

G B Yao1.   

Abstract

China has one of the highest rates of hepatitis B virus (HBV) endemicity in the world. In a survey of five provinces, the overall HBV infection rate in the general population was found to be 42.6%, with 10.3% testing positive for hepatitis B surface antigen (HBsAg). Higher rates were found in rural than in urban areas. The prevalence of HBsAg among children under 1 year of age is quite low but increases rapidly thereafter, reaching a peak among 5 to 9 year olds. The pattern of age distribution suggests that horizontal transmission is an important route of HBV infection during early childhood, and the proportion of chronic HBsAg carriage attributable to perinatal transmission has been estimated at only 13-20%. Contact with infected family members probably accounts for much of the horizontal transmission in children. In a nationwide survey, 27.2% of families were found to have one or more HBsAg positive members and a strong tendency for family clustering has been identified. The strategy for prevention of HBV infection includes vaccination of all newborns, whether their mothers are HBsAg positive or negative, together with vaccination of high risk populations, and improved control measures in clinics and blood transfusion centres.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786052      PMCID: PMC1398042          DOI: 10.1136/gut.38.suppl_2.s39

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

1.  Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.

Authors:  Shan Gao; Wan-Shui Yang; Freddie Bray; Puthiery Va; Wei Zhang; Jing Gao; Yong-Bing Xiang
Journal:  Eur J Epidemiol       Date:  2011-12-10       Impact factor: 8.082

Review 2.  Getting married in China: pass the medical first.

Authors:  Therese Hesketh
Journal:  BMJ       Date:  2003-02-01

3.  Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assay.

Authors:  Yao Zhao; Xiu-Yu Zhang; Jin-Jun Guo; Ai-Zhong Zeng; Jie-Li Hu; Wen-Xiang Huang; You-Lan Shan; Ai-Long Huang
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

Review 4.  Hepatitis B (prevention).

Authors:  Suzanne Norris; Abdul Mohsen
Journal:  BMJ Clin Evid       Date:  2009-09-23

5.  Prevalence of TT virus and GBV-C infections among patients with liver diseases and the general population in Shanghai, China.

Authors:  X Ding; M Mizokami; L Y Kang; K Cao; E Orito; Y Tanaka; R Ueda; M Sasaki
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

6.  Hepatitis B virus infection among Chinese residents in the United Kingdom.

Authors:  M Kawsar; B T Goh
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

7.  Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission.

Authors:  Hartono Gunardi; Melanie Y Iskandar; Susan I Ie; Pramita G Dwipoerwantoro; Rino A Gani; David H Muljono
Journal:  Hepatol Int       Date:  2016-09-13       Impact factor: 6.047

8.  Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications.

Authors:  Manju Rani; Baoping Yang; Richard Nesbit
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

9.  Hepatitis B Therapy in Pregnancy.

Authors:  Natalie H Bzowej
Journal:  Curr Hepat Rep       Date:  2010-09-09

10.  Vitamin E treatment for children with chronic hepatitis B: a randomized placebo controlled trial.

Authors:  Patrick Gerner; Hans-Georg Posselt; Andreas Krahl; Antje Ballauff; Albina Innerhofer; Christa Binder; Tobias G Wenzl; Matthias Zense; Ariadne Hector; Gerhard Dockter; Rüdiger Adam; Jenny Neubert; Martin Classen; Robert van Gemmern; Stefan Wirth
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.